December 15, 2019 On Sunday, the Der lab prepared a taco bar for the guests at the Family House. Together, they made ground beef, rice, beans, vegetables, and homemade pico de gallo served in soft tacos, as well as cookies and sweet tea. The Der lab also had the opportunity to sit down and eat … Continue reading Der Lab Volunteers at SECU Family House
Come out to support Aaron Hobbs as he presents "Atypical KRASG12R mutant is impaired in PI3K signaling and macropinocytosis in pancreatic cancer." The talks will be held in the Pagano Conference Room on Monday, December 16th at 12:00 pm.
Channing Der has been named a Fellow of the American Association for the Advancement of Science (AAAS) for “distinguished contributions to the field of cancer research through the discovery of RAS in cancer and the elucidation of RAS oncoprotein function and therapies.” Der, who joined the UNC School of Medicine in 1992 as an associate … Continue reading Channing Der Named AAAS Fellow
For the month of November, the Der and Cox labs have gone purely purple. The dress code is inspired by the official pancreatic cancer ribbon and is worn all month to bring awareness to pancreatic cancer. See ABC 11's interview with Dr. Jen Jen Yeh and Dr. Kirsten Bryant here. Photos courtesy of the UNC … Continue reading Der Lab Goes Purple for Pancreatic Awareness
A new study from University of North Carolina Lineberger Comprehensive Cancer Center researchers reveals important findings about how a common genetic mutation in pancreatic cancer works to drive tumor growth. In the journal Cancer Discovery, researchers led by UNC Lineberger’s Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of a particular mutation … Continue reading Researchers find KRAS gene mutation differences have implications for pancreatic cancer treatment
Cancer survivors, patients, caregivers, and friends, gathered for an awareness reception at Hollings Cancer Center at the Medical University of South Carolina (MUSC). Dr. Channing Der spoke on the latest developments in pancreatic cancer research and treatments. More on the event at MUSC.
Two new drugs finally hit ‘undruggable’ cancer target, providing hope for treatments By Jocelyn Kaiser Cancer researchers are making progress toward a goal that has eluded them for more than 30 years: shrinking tumors by shutting off a protein called KRAS that drives growth in many cancer types. A new type of drug aimed at KRAS … Continue reading Channing Der Interviewed by Science Magazine
Congratulations to Der Lab member, Clint Stalnecker, for winning first place in an oral research presentation competition at the 44th Annual Postdoc-Faculty Research Day! Read more about the 44th Annual Postdoc Faculty Research Day.
Right DirectionThe findings follow data this summer that showed half of those treated with Amgen’s drug at a wide range of doses responded. The latest results more than doubled the number of patients treated with the highest dose and tracked them for three more months. It’s too early to know how long the benefits will last and … Continue reading Channing Der Quoted by Bloomberg
September 4, 2019 Congratulations to Kirsten Bryant, Ph.D., for her acceptance of the Joseph S. Pagano Award! This award recognizes outstanding work by the Lineberger’s postdoctoral research associates. We are proud of Kirsten's accomplishments. Read more about Kirsten's award ceremony.